Chalk up one more addition to the Kansas City region as a global center of excellence in animal health: San Francisco-based Kindred Biosciences announced today that it will open its first regional location at a manufacturing facility in Elwood, Kan., near St. Joseph, Mo.
“We are very excited to become a brick-and-mortar addition to the Kansas City Animal Health Corridor,” said Denise Bevers, the company’s co-founder and COO, in a news release announcing the move. “While we already employ top talent in the Kansas area, this acquisition will allow us to recruit additional talent to support the manufacture of drugs and biologics for companion animals.”
Kimberly Young, president of the KC Animal Health Corridor, issued a statement saying KindredBio’s move into the region demonstrated that “more and more, the growth of the animal-health industry in the corridor is reliant on young companies taking innovative products and services from the lab to the marketplace.”
Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. It identifies compounds and targets that have already demonstrated safety and efficacy in humans and develops therapeutics based on these validated compounds and targets for dogs, cats and horses. It has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.